Two Treatments Show Benefits in Juvenile Myasthenia Gravis

(MedPage Today) — SAN FRANCISCO — Two studies demonstrated the benefits of treating juvenile myasthenia gravis (MG) with newer drugs.
Interim results from the phase II/III ADAPT Jr study showed that efgartigimod (Vyvgart), a drug approved…

Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118275

Author :

Publish date : 2025-11-03 16:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Two Treatments Show Benefits in Juvenile Myasthenia Gravis

The anthropologist shaking up the way we name human species

Walking 3000 steps a day seems to slow Alzheimer’s-related decline

Related Posts

Supplement Yanked Over Suicide Risk; ‘Dilbert’ Creator Dies; Full-Body Scan Lawsuit

More People Survive Cancer, Report Shows

Are Cardiologists Overlooking Substance Use Risk?

‘It’s life-changing. I can see my child grow up’

Sleeping With the Light on May Increase Heart Disease Risk

What Do the New VCID Guidelines Mean for Clinical Practice?

Supplement Yanked Over Suicide Risk; ‘Dilbert’ Creator Dies; Full-Body Scan Lawsuit

More People Survive Cancer, Report Shows

Are Cardiologists Overlooking Substance Use Risk?

‘It’s life-changing. I can see my child grow up’

Sleeping With the Light on May Increase Heart Disease Risk

What Do the New VCID Guidelines Mean for Clinical Practice?

Could AI Help Predict the Next Pandemic?

We must completely change the way we build homes to stay below 2°C

Categories

Archives